Department of Biomedical, Experimental, and Clinical Sciences "Mario Serio", University of Florence, Viale Morgagni 85, 50134, Florence, Italy.
Radiation Oncology Unit, University of Florence, Florence, Italy.
Support Care Cancer. 2021 Jun;29(6):2931-2937. doi: 10.1007/s00520-020-05793-3. Epub 2020 Oct 2.
In the last months, Italy faced a COVID-19 emergency and implemented preventive measures in order to protect patients and healthcare providers from a disease outbreak. The pandemic control strategies impacted patient experience directly. Questionnaires evaluating patients reported measures (PREMs) may assess critical issues and represent a helpful tool to measure the patient perception of healthcare service. Our aim was to prospectively assess patient satisfaction about doctor-patient interaction in a high-volume radiation therapy and oncology center during the COVID-19 pandemic.
Cancer patients receiving either systemic and/or radiation treatment underwent a survey. Two validated questionnaires (EORTC QLQ-C30, FACIT-TS-G version 1) and 14 specific questions evaluating patients' perception of COVID-19 measures were administered.
One hundred twenty-five patients admitted to our department from 1-30 April 2020 completed the questionnaires. The majority (66.4%) of patients were women and the most common disease was breast cancer (40%). The average Global Health Status (GHS) of EORTC QLQ-C30 was 61.67. Emotional functioning, social, and cognitive domains obtained scores of 75.48, 80.13, and 84.67, respectively. FACIT-TS-G results revealed 120 patients rated the treatments effective and 108 patients thought the side effects were the same as expected or better. Most (89.6%) rated their treatment good, very good, or excellent. Concerning COVID-19-related questions, patients reported overall very good level of information.
Despite the introduction of strict COVID-19 control measures, there was a high level of cancer outpatient satisfaction. The satisfaction levels may influence compliance, continuity of treatments, and patient-doctor communication, impacting the quality of clinical care in the next phases of the pandemic.
在过去的几个月里,意大利面临着 COVID-19 紧急情况,并采取了预防措施,以保护患者和医疗保健提供者免受疾病爆发的影响。大流行控制策略直接影响了患者体验。评估患者报告措施的问卷(PREMs)可评估关键问题,是衡量医疗保健服务患者感知的有用工具。我们的目的是前瞻性评估在 COVID-19 大流行期间,在一家大容量放疗和肿瘤中心,患者对医患互动的满意度。
接受系统治疗和/或放疗的癌症患者接受了调查。使用了两个经过验证的问卷(EORTC QLQ-C30、FACIT-TS-G 版本 1)和 14 个评估患者对 COVID-19 措施感知的特定问题。
2020 年 4 月 1 日至 30 日期间,我院 125 名患者完成了问卷。大多数(66.4%)患者为女性,最常见的疾病是乳腺癌(40%)。EORTC QLQ-C30 的平均总体健康状况(GHS)得分为 61.67。情绪功能、社会和认知领域的得分分别为 75.48、80.13 和 84.67。FACIT-TS-G 的结果显示,120 名患者认为治疗有效,108 名患者认为副作用与预期相同或更好。大多数(89.6%)患者认为他们的治疗良好、非常好或极好。关于 COVID-19 相关问题,患者报告了总体非常好的信息水平。
尽管采取了严格的 COVID-19 控制措施,但仍有很高水平的癌症门诊患者满意度。满意度水平可能会影响依从性、治疗的连续性和医患沟通,从而影响大流行下一阶段的临床护理质量。